Press releases
- LivaNova Reports First-Quarter 2023 Results
- LivaNova Board of Directors Announce Leadership Changes
- LivaNova to Announce First-Quarter 2023 Results
- LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures
- LivaNova to Present at the Barclays Global Healthcare Conference
More ▼
Key statistics
On Tuesday, LivaNova PLC (L2IV34:SAO) closed at 41.65, 0.00% below its 52-week high of 41.65, set on Jul 26, 2022.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 41.65 |
Average volume | -- |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jul 26 2022.
More ▼